USPTO serial 79311502
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
JP
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey L. Costellia
Jeffrey L. Costellia NIXON PEABODY LLP799 9th Street, NW, Suite 500WASHINGTON, DC 20001UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treatment of porphyrin metabolism disorders; pharmaceutical preparations for treatment of porphyria; pharmaceutical preparations for treatment of photodermatoses; pharmaceutical preparations for treatment of scleroderma | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 12, 2022 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 19, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 25, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |